These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10970378)

  • 1. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.
    Tondella ML; Popovic T; Rosenstein NE; Lake DB; Carlone GM; Mayer LW; Perkins BA
    J Clin Microbiol; 2000 Sep; 38(9):3323-8. PubMed ID: 10970378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
    Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
    J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.
    Martin SL; Borrow R; van der Ley P; Dawson M; Fox AJ; Cartwright KA
    Vaccine; 2000 May; 18(23):2476-81. PubMed ID: 10775781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.
    Matthias KA; Reveille A; Connolly KL; Jerse AE; Gao YS; Bash MC
    Vaccine; 2020 Feb; 38(10):2396-2405. PubMed ID: 32037226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
    Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.
    Sacchi CT; Whitney AM; Popovic T; Beall DS; Reeves MW; Plikaytis BD; Rosenstein NE; Perkins BA; Tondella ML; Mayer LW
    J Infect Dis; 2000 Oct; 182(4):1169-76. PubMed ID: 10979914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van Dijken H; Kuipers B; van der Biezen J; van der Ley P; Meylis J; Claassen I; Poolman J
    Infect Immun; 1997 Dec; 65(12):5184-90. PubMed ID: 9393814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
    Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
    Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.
    Humphries HE; Williams JN; Blackstone R; Jolley KA; Yuen HM; Christodoulides M; Heckels JE
    Vaccine; 2006 Jan; 24(1):36-44. PubMed ID: 16105711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive meningococcal disease in Scotland, 1994 to 1999, with emphasis on group B meningococcal disease.
    Kyaw MH; Clarke SC; Christie P; Jones IG; Campbell H
    J Clin Microbiol; 2002 May; 40(5):1834-7. PubMed ID: 11980971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system.
    Sacchi CT; Lemos AP; Whitney AM; Solari CA; Brandt ME; Melles CE; Frasch CE; Mayer LW
    Clin Diagn Lab Immunol; 1998 May; 5(3):348-54. PubMed ID: 9605990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.
    Milagres LG; Gorla MC; Sacchi CT; Rodrigues MM
    Infect Immun; 1998 Oct; 66(10):4755-61. PubMed ID: 9746575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.
    Sorhouet Pereira C; Regueira M; Mollerach M
    J Med Microbiol; 2008 Mar; 57(Pt 3):338-342. PubMed ID: 18287297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.
    Lehmann AK; Halstensen A; Aaberge IS; Holst J; Michaelsen TE; Sornes S; Wetzler LM; Guttormsen H
    Infect Immun; 1999 May; 67(5):2552-60. PubMed ID: 10225920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic assessment of Neisseria meningitidis isolates obtained from patients with invasive meningococcal disease in Greece, 1993-2003: implications for serogroup B vaccines based on PorA serosubtype antigens.
    Tzankaki G; Markou F; Kesanopoulos K; Levidiotou S; Pangalis A; Tsolia M; Liakou V; Papapavasiliou E; Voyiatzi A; Kansouzidou A; Foustoukou M; Blackwell C; Kremastinou J
    Vaccine; 2006 Feb; 24(6):819-25. PubMed ID: 16153759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic diversity of Neisseria meningitidis isolated in Taiwan between 1995 and 2002.
    Yang CY; Lee YS; Huang LS; Kuo YL; Liu YL; Lu CH
    Scand J Infect Dis; 2006; 38(4):273-80. PubMed ID: 16709528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
    Toropainen M; Saarinen L; van der Ley P; Kuipers B; Käyhty H
    Microb Pathog; 2001 Mar; 30(3):139-48. PubMed ID: 11273739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of PorA during a meningococcal disease epidemic.
    Devoy AF; Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements.
    Wedege E; Bolstad K; Wetzler LM; Guttormsen H
    J Immunol Methods; 2000 Oct; 244(1-2):9-15. PubMed ID: 11033014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.